Table 3.
Baseline Variables Associated with Changes in Viral Load Count
| Predictor Variables | Viral Load Count (Log-Transformed) | P-value | ||
|---|---|---|---|---|
| Coefficient (β) | 95% CI | |||
| Lower Bound | Upper Bound | |||
| Age (1-year increase) | 0.03 | 0.01 | 0.14 | 0.001 |
| Sex | ||||
| Male | 0.30 | −0.81 | 0.54 | 0.153 |
| Female | Ref. | Ref. | Ref. | |
| Residence | ||||
| Urban | −0.55 | −0.63 | −0.34 | 0.009 |
| Rural | Ref. | Ref. | Ref. | |
| Educational status | ||||
| Cannot read and write | 0.48 | −0.72 | 0.61 | 0.074 |
| Primary | −0.12 | −0.08 | 0.10 | 0.615 |
| Secondary and above | Ref. | Ref. | Ref. | |
| Baseline CD4 count | ||||
| <200 | −0.17 | −0.29 | 0.21 | 0.565 |
| 201–500 | −0.67 | −0.87 | −0.43 | 0.045 |
| ≥500 | Ref. | Ref. | Ref. | Ref. |
| Duration on ART in months | −0.01 | −0.01 | −0.02 | 0.004 |
| Baseline WHO clinical stage | ||||
| Stage 1 | −0.11 | −0.33 | 0.05 | 0.777 |
| Stage 2 or 3 | Ref. | Ref. | Ref. | |
Abbreviations: ART, antiretroviral therapy; Ref, reference; WHO, World Health Organization.